1 Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
2 Physiotherapy Department, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa.
Clin Rehabil. 2019 Feb;33(2):222-232. doi: 10.1177/0269215518800832. Epub 2018 Sep 24.
: To determine the cost-effectiveness of the HiBalance training program for managing Parkinson's disease (PD)-related balance and gait disorders.
: Cost comparison design following the randomized controlled trial comparing a novel balance training intervention with care as usual.
: A total of 100 participants with mild-moderate PD were randomized to either the intervention ( n = 51) or the control group ( n = 49).
: A 10-week (three times per week), group-based, progressive balance training program, led by two physical therapists.
: All program costs were collected for both groups. Cost-utility was evaluated using quality-adjusted life years (QALYs) and cost-effectiveness measures were the Mini Balance Evaluation Systems Test (Mini-BESTest; assessing balance performance) and gait velocity. Incremental cost-effectiveness ratios were calculated and a probabilistic sensitivity analysis was conducted.
: The between-group difference in QALYs was 0.043 (95% confidence interval (CI): 0.011-0.075), favoring the intervention group. Between-group differences in balance performance and gait velocity were 2.16 points (95% CI: 1.19-3.13) and 8.2 cm/second (95% CI: 2.9-13.6), respectively, favoring the intervention group. The mean cost per participant in the intervention group was 16,222 SEK (€1649) compared to 2696 SEK (€274) for controls. The estimated incremental cost-effectiveness ratios were 314,558 SEK (€31,969) for an additional QALY, 6262 SEK (€631) for one point improvement in balance performance, and 1650 SEK (€166) for 1 cm/second increase in gait velocity. Sensitivity analyses indicated a high probability (85%) of program success.
: In terms of QALYs, the HiBalance program demonstrated a high probability of cost-effectiveness in the short-term perspective when considering the willingness-to-pay thresholds used in Europe.
确定 HiBalance 训练计划在管理帕金森病(PD)相关平衡和步态障碍方面的成本效益。
随机对照试验后进行成本比较设计,比较新的平衡训练干预与常规护理。
共 100 名轻度至中度 PD 患者随机分为干预组(n=51)或对照组(n=49)。
一项为期 10 周(每周 3 次)、基于小组的、渐进式平衡训练计划,由两名物理治疗师领导。
收集了两组的所有项目成本。使用质量调整生命年(QALYs)评估成本效益,平衡表现采用 Mini-Balance Evaluation Systems Test(Mini-BESTest)和步态速度进行评估。计算了增量成本效益比,并进行了概率敏感性分析。
干预组和对照组的 QALY 之间存在 0.043(95%置信区间(CI):0.011-0.075)的差异,有利于干预组。平衡表现和步态速度的组间差异分别为 2.16 分(95% CI:1.19-3.13)和 8.2cm/秒(95% CI:2.9-13.6),也有利于干预组。干预组每名参与者的平均费用为 16222 瑞典克朗(€1649),而对照组为 2696 瑞典克朗(€274)。增量成本效益比估计为每增加一个 QALY 需额外支付 314558 瑞典克朗(€31969),平衡表现提高 1 分需额外支付 6262 瑞典克朗(€631),步态速度提高 1cm/秒需额外支付 1650 瑞典克朗(€166)。敏感性分析表明,方案成功的可能性很高(85%)。
从 QALYs 的角度来看,考虑到欧洲使用的意愿支付阈值,HiBalance 计划在短期内具有很高的成本效益可能性。